BioMarin Pharmaceutical Inc. (BMRN)
Analyst consensus, price target and coverage. 25 analysts, updated daily.
Analyst votes
How the ratings break down
25 ratings on record
- Strong Buy6
- Buy13
- Hold6
- Underperform0
- Sell0
Price targets
Where the estimates sit
How far apart analysts are on this name.
Low 60.00
Mean 90.32
High 124.00
share price 68.53 mean target 90.32. Analysts are spread 107% apart.
Most recent action
Last rating change
| Firm | Canaccord Genuity |
|---|---|
| Date | 2026-08-10 |
| Change | Buy → Buy |
Size and liquidity
Key statistics
| Market cap | 13.27B USD |
|---|---|
| Cap class | Large |
| Average volume | 2,187,456 |
| Dollar volume per day | 149.9M |
| Liquidity | High |
| Internal score | 78.8 / 100 |
Recommendation
How it moved, scan by scan
3 scans on record
| Scan | Move | Consensus | Score | SB | Buy | Hold | Und | Sell |
|---|---|---|---|---|---|---|---|---|
| 2026-08-14 10:42 | = | Buy | 2.00 | 6 | 13 | 6 | 0 | 0 |
| 2026-08-13 | = | Buy | 2.00 | 6 | 13 | 6 | 0 | 0 |
| 2026-08-11 | · | Buy | 2.00 | 6 | 13 | 6 | 0 | 0 |
Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. ▲ more positive, ▼ more negative, = unchanged.
History
Price target over time
3 daily points recorded
| Date | Price | Target | Upside | Consensus |
|---|---|---|---|---|
| 2026-08-14 | 68.53 | 90.32 | +31.8% | Buy |
| 2026-08-13 | 70.24 | 90.32 | +28.6% | Buy |
| 2026-08-11 | 69.64 | 90.32 | +29.7% | Buy |
Similar coverage
Comparable large-cap names
Closest upside among companies of the same size.